Clinical Trial Update: Granulocyte-colony Stimulating Factors or Antibiotics for Primary Prophylaxis for Febrile Neutropenia [Phase 4]

View source ↗

Summary

Phase 4 trial update on agents for primary prophylaxis of febrile neutropenia in early stage breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Early Stage Breast Cancer | Phase 4 | Status: COMPLETED